Project Grant R01DK140284
- This $205,000 project grant from the National Institutes of Health's National Institute on Aging will fund research into the pathomechanics of diabetic foot ulcers at The University of Texas Southwestern Medical Center over a 12-month period. The research aims to identify more accurate markers and marker combinations for foot ulceration risk in patients with diabetic neuropathy and a history of prior ulcers. Using specialized equipment, the study will quantify two primary ulcer-causing...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $555,034 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Emory University. The project, titled "Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation (CARE-D-FOOT-NAV), A Randomized Controlled Trial", aims to assess the impact of a comprehensive patient navigator program on improving diabetic foot ulcer (DFU) care...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded a $389,019 Project Grant to Koronis Biomedical Technologies Corp. (KBT) to evaluate the feasibility of using an innovative smart offloading ankle foot orthosis (AFO) to treat patients with diabetic foot ulcers, Charcot neuroarthropathy, and other below-the-knee orthopedic traumas. The proposed smart AFO allows...
- This federal Project Grant award of $1,024,812 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to develop novel treatments for diabetic foot ulcers (DFU). The award supports research conducted by Epoulosis Therapeutics Inc. to leverage single-cell RNA sequencing data and in vivo studies to repurpose the drug metrifonate for enhancing wound healing in DFU...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $687,416 Project Grant under CFDA 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research) to Lynntech Inc., a small business technology development company based in College Station, Texas. The grant will support the development of a cutaneous gel to deliver a therapeutic with an intriguing mechanism of action to effectively treat diabetic foot ulcers (DFUs). The project aims to: (1) prepare,...
- This federal Project Grant award of $1,187,347.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) will support research conducted by the University of California, San Diego (UC San Diego) to develop photoacoustic imaging tools to monitor and predict the response to treatment for diabetic foot ulcers (DFUs). The research aims to validate imaging biomarkers that can measure tissue perfusion and...
- This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $268,377 to The University of North Texas Health Science Center at Fort Worth (UNTHSC) to develop and evaluate a novel device for accelerating the healing of diabetic foot ulcers (DFUs) using high-frequency, low-amplitude vibration (HFLAV). The key objectives are to: 1) enhance...
- This Project Grant award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program will fund the development of an advanced wound care product to treat diabetic foot ulcers. The $305,000 award to Therapeutic Bandage Products, Inc. will support the creation of a patented microneedle bandage that delivers three therapeutic agents to disinfect the wound, prevent bacterial biofilm formation, and attract white blood cells to aid healing. This...
- The National Science Foundation (NSF) awarded a $295,000 SBIR Phase I Project Grant under the Technology, Innovation, and Partnerships (CFDA 47.084) program to Biodynamik, a small business located in Lake Forest, CA. The grant supports the development and testing of a novel implantable system that leverages distraction osteogenesis as a treatment for diabetic foot ulcers (DFUs). The project aims to design and develop a low-profile, transverse tibial transport device with an active mechanical...
- The federal Project Grant award, "GLUCOSE PATTERNS AND CLINICAL OUTCOMES IN THE DALLAS HEART STUDY: A PATHWAY TO PRECISION DIABETES - CONTINUOUS GLUCOSE MONITORING (CGM) SYSTEMS", is provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $819,091 award to The Johns Hopkins University will fund research to use CGM and machine learning methods to identify...
This Project Grant award of $806,274 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) supports the development of "Wearable Insoles for Recurrent Diabetic Ulcer Prevention (WIREDUP)". The goal is to evaluate the effectiveness of an interactive sensory insole device in reducing the recurrence of diabetic foot ulcers (DFUs) in adults with diabetes. The project will be conducted by The Johns Hopkins University, a leading federal research grantee, and will run from September 2025 through June 2030. The interactive insole technology aims to provide real-time monitoring and cues to patients to help offload pressure from areas at risk of DFU development, with the potential to significantly reduce ulcer recurrence rates compared to standard offloading approaches.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $806.3k | 9/10/25 |